Teresa J Hudson1, John C Fortney, Jeffrey M Pyne, Liya Lu, Dinesh Mittal. 1. The authors are with the Department of Psychiatry, University of Arkansas for Medical Sciences, Little Rock (e-mail: teresa.hudson@va.gov ). Except for Ms. Lu, the authors are also with Health Services Research and Development, Central Arkansas Veterans Healthcare System, North Little Rock. A similar draft of this article was based on a slightly different analytic model and was presented in a poster titled "Improving Health Through Research and Training" at the Translational Science meeting, Washington, D.C., April 18-20, 2012.
Abstract
OBJECTIVE: Antidepressants are effective for treating depression, and collaborative care increases initiation of and adherence to antidepressants. Side effects of antidepressants are common and can adversely affect quality of life. Care managers address antidepressant side effects directly, but the impact of collaborative care on adverse effects is unknown. This secondary data analysis tested the hypothesis that patient-reported antidepressant side effects were lower for depressed patients receiving high-intensity, telemedicine-based collaborative care (TBCC) than for patients receiving low-intensity, practice-based collaborative care (PBCC). METHODS: This analysis used data from 190 patients enrolled in a pragmatic, multisite, comparative-effectiveness trial from 2007 to 2009 and followed for 18 months. Most patients were female (83%) and Caucasian (80%). The mean age was 50. Patients randomly assigned to PBCC received 12 months of evidence-based care from an on-site primary care provider and nurse care manager. Patients in TBCC received evidence-based care from an on-site primary care provider supported by a nurse care manager available off site by telephone, as well as by a telepharmacist, telepsychologist, and telepsychiatrist. Telephone interviews completed at baseline, six, 12, and 18 months included assessments of sociodemographic characteristics, beliefs about antidepressant treatment, depression severity, psychiatric comorbidity, medications, adherence, and side effects. RESULTS: With controls for baseline case mix and time-variant medication characteristics, the TBCC group reported significantly fewer side effects at six and 12 months (p=.008 and .002, respectively). The number of antidepressants prescribed increased risk of side effects (p=.02). CONCLUSIONS: Patients in the TBCC group reported fewer antidepressant-related side effects, which may have contributed to improved quality of life.
RCT Entities:
OBJECTIVE: Antidepressants are effective for treating depression, and collaborative care increases initiation of and adherence to antidepressants. Side effects of antidepressants are common and can adversely affect quality of life. Care managers address antidepressant side effects directly, but the impact of collaborative care on adverse effects is unknown. This secondary data analysis tested the hypothesis that patient-reported antidepressant side effects were lower for depressedpatients receiving high-intensity, telemedicine-based collaborative care (TBCC) than for patients receiving low-intensity, practice-based collaborative care (PBCC). METHODS: This analysis used data from 190 patients enrolled in a pragmatic, multisite, comparative-effectiveness trial from 2007 to 2009 and followed for 18 months. Most patients were female (83%) and Caucasian (80%). The mean age was 50. Patients randomly assigned to PBCC received 12 months of evidence-based care from an on-site primary care provider and nurse care manager. Patients in TBCC received evidence-based care from an on-site primary care provider supported by a nurse care manager available off site by telephone, as well as by a telepharmacist, telepsychologist, and telepsychiatrist. Telephone interviews completed at baseline, six, 12, and 18 months included assessments of sociodemographic characteristics, beliefs about antidepressant treatment, depression severity, psychiatric comorbidity, medications, adherence, and side effects. RESULTS: With controls for baseline case mix and time-variant medication characteristics, the TBCC group reported significantly fewer side effects at six and 12 months (p=.008 and .002, respectively). The number of antidepressants prescribed increased risk of side effects (p=.02). CONCLUSIONS:Patients in the TBCC group reported fewer antidepressant-related side effects, which may have contributed to improved quality of life.
Authors: Gerald Gartlehner; Richard A Hansen; Laura C Morgan; Kylie Thaler; Linda Lux; Megan Van Noord; Ursula Mager; Patricia Thieda; Bradley N Gaynes; Tania Wilkins; Michaela Strobelberger; Stacey Lloyd; Ursula Reichenpfader; Kathleen N Lohr Journal: Ann Intern Med Date: 2011-12-06 Impact factor: 25.391
Authors: K B Wells; C Sherbourne; M Schoenbaum; N Duan; L Meredith; J Unützer; J Miranda; M F Carney; L V Rubenstein Journal: JAMA Date: 2000-01-12 Impact factor: 56.272
Authors: Tami L Mark; Vijay N Joish; Joel W Hay; David V Sheehan; Stephen S Johnston; Zhun Cao Journal: Am J Geriatr Psychiatry Date: 2011-03 Impact factor: 4.105
Authors: Madhukar H Trivedi; A John Rush; Stephen R Wisniewski; Andrew A Nierenberg; Diane Warden; Louise Ritz; Grayson Norquist; Robert H Howland; Barry Lebowitz; Patrick J McGrath; Kathy Shores-Wilson; Melanie M Biggs; G K Balasubramani; Maurizio Fava Journal: Am J Psychiatry Date: 2006-01 Impact factor: 18.112
Authors: G E Simon; E H Lin; W Katon; K Saunders; M VonKorff; E Walker; T Bush; P Robinson Journal: J Gen Intern Med Date: 1995-12 Impact factor: 5.128
Authors: John W Williams; Martha Gerrity; Tracey Holsinger; Steve Dobscha; Bradley Gaynes; Allen Dietrich Journal: Gen Hosp Psychiatry Date: 2007 Mar-Apr Impact factor: 3.238